IP Library Granted Patent US 10,653,736
Granted Patent B2
US 10,653,736 · App. 16/257,389 · Granted May 19, 2020

Topical treatments incorporating

Inventors: Ronald D. Sekura (Key Largo, FL); Roscoe M. Moore (Rockville, MD)
A61K36/185A61K8/498A61K9/0014A61K9/0034A61K9/0043A61K9/06A61K9/08A61K31/045A61K31/047A61K31/05A61K31/085A61K31/12A61K31/235A61K31/245A61K31/352A61K31/573A61K31/618A61K36/00A61K36/61A61K45/06A61K47/12A61K47/44A61P17/06A61Q5/006A61Q5/02A61Q19/00A61Q19/001
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,653,736
App. No.
16/257,389
Granted
May 19, 2020
Kind
B2
Abstract

A topical formulation comprising a Cannabis derived botanical drug product, wherein the concentration of tetrahydrocannabinol, cannabidiol, or both in the topical formulation is greater than 2 milligrams per kilogram.

Claims (14)

1. A topical formulation, consisting essentially of:

an extract of Cannabis sativa or Cannabis indica;

at least one compound selected from the group consisting of menthol, resorcinol, and phenol, present in an amount of at least 0.1 wt % in the topical formulation,

wherein a concentration of at least one component selected from the group consisting of tetrahydrocannabinol and cannabidiol in the topical formulation is greater than 2 milligrams per kilogram, and

wherein the topical formulation is obtained by dispersing the extract of Cannabis sativa or Cannabis indica in a water-in-oil emulsion, an oil-in-water emulsion, a wax-in-oil base, or an oil-in-wax base.

2. The topical formulation of claim 1 , wherein the extract is an extract of Cannabis sativa.

3. The topical formulation of claim 1 , wherein the extract is an extract of Cannabis indica.

4. The topical formulation of claim 1 , wherein the concentration of the at least one selected from the group consisting of tetrahydrocannabinol and cannabidiol in the topical formulation is from 2 to 100 milligrams per kilogram.

5. The topical formulation of claim 1 , wherein the concentration of the at least one selected from the group consisting of tetrahydrocannabinol and cannabidiol in the topical formulation is from 2 to 25 milligrams per kilogram.

6. The topical formulation of claim 1 , wherein the at least one compound selected from the group consisting of menthol, resorcinol, and phenol is present in an amount from 0.1-5 wt %, based on a total weight of the topical formulation.

7. The topical formulation of claim 1 , wherein the at least one compound selected from the group consisting of menthol, resorcinol, and phenol is present in an amount from 0.1-5 wt %, based on a total weight of the topical formulation.

8. The topical formulation of claim 1 , wherein the compound is menthol.

9. The topical formulation of claim 1 , wherein the compound is resorcinol.

10. The topical formulation of claim 1 , wherein the compound is phenol.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jun 21, 2024
From: SEKURA, RONALD D.; MOORE, ROSCOE M.
To: METRONOME LLC
Reel/Frame 067795/0760 →
Continuity (5)
Continuation 15914064 · Mar 7, 2018
Continuation 14750558 · Jun 25, 2015
Continuation 14498555 · Sep 26, 2014
Provisional Application 61882990 · Sep 26, 2013
Related Publication 20190175675A1 · Jun 13, 2019